Therapeutic BCL11A enhancer gene editing to induce fetal hemoglobin in β-hemoglobinopathy patients

NIH RePORTER · NIH · OT2 · $1,716,494 · view on reporter.nih.gov ↗

Abstract

No abstract provided

Key facts

NIH application ID
10090251
Project number
1OT2HL154984-01
Recipient
BOSTON CHILDREN'S HOSPITAL
Principal Investigator
Daniel Evan Bauer
Activity code
OT2
Funding institute
NIH
Fiscal year
2020
Award amount
$1,716,494
Award type
1
Project period
2020-06-18 → 2022-11-30